Randomized comparison between clinical evaluation plus N-terminal pro-B-type natriuretic peptide versus exercise testing for decision making in acute chest pain of uncertain origin

American Heart Journal

Volumn 159, Issue 2, 2010, Pages 176-182

  Sanchis, Juan ^a   Bosch, Xavier ^b   Bodí, Vicente ^a   Núñez, Julio ^a   Doltra, Ada ^b   Heras, Magda ^b   Mainar, Luis ^a   Santas, Enrique ^a   Bragulat, Ernest ^b   García Alvarez, Ana ^b   Carratalá, Arturo ^a   Llácer, Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOASSAY; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; THORAX PAIN;

ACUTE DISEASE; CHEST PAIN; EXERCISE TEST; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE; PROSPECTIVE STUDIES;

EID: 75249090176     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.11.010     Document Type: Article

References (26)

1. Sanchis J., Bodí V., Núñez J., et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. J Am Coll Cardiol 46 (2005) 443-449
2. Farkouh M.E., Smars P.A., Reeder G.S., et al. A clinical trial of a chest-pain observation unit for patients with unstable angina. N Eng J Med 339 (1998) 1882-1888
3. Diercks D.B., Gibler B., Liu T., et al. Identification of patients at risk by graded exercise testing in an emergency department chest pain center. Am J Cardiol 86 (2000) 289-292
4. Amsterdam E.A., Kirk J.D., Diercks D.B., et al. Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain. J Am Coll Cardiol 40 (2002) 251-256
5. Sanchis J., Bodí V., Llácer A., et al. Exercise testing in a chest pain unit. Rev Esp Cardiol 55 (2002) 1089-1092
6. Ramakrishna G., Milavetz J.J., Zinsmeister A.R., et al. Effect of exercise treadmill testing and stress imaging on the triage of patients with chest pain: CHEER substudy. Mayo Clin Proc 80 (2005) 322-339
7. Sanchis J., Bodí V., Núñez V., et al. Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without preexisting evidence of myocardial ischemia. Am J Cardiol 97 (2006) 633-635
8. Jeetley P., Burden L., Stoykova B., et al. Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study. Eur Heart J 28 (2007) 204-211
9. Candell Riera J., Oller Martínez G., de León G., et al. Yield of early rest and stress myocardial perfusion single-photon emission computed tomography and electrocardiographic exercise test in patients with atypical chest pain, nondiagnostic electrocardiogram and negative biochemical markers in the emergency department. Am J Cardiol 99 (2007) 1662-1666
10. Goldstein J.A., Gallagher M.J., O'Neill W.W., et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 49 (2007) 863-871
11. Sanchis J., Bosch X., Bodí V., et al. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain, without ST-segment deviation or troponin elevation. Heart 94 (2008) 311-315
12. Geleijnse M.L., Elhendy A., Kasprzak J.D., et al. Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J 21 (2000) 397-406
13. Sanchis J., Bodí V., Núñez J., et al. A practical approach with outcome for the prognostic assessment of non-ST-Segment elevation chest pain and normal troponin. Am J Cardiol 99 (2007) 707-801
14. Antman E.M., Cohen M., Bernink P.J.L.M., et al. The TIMI risk score for unstable angina / non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
15. Sanchis J., Bodí V., Llácer A., et al. Emergency room risk stratification of patients with chest pain without ST-segment elevation. Rev Esp Cardiol 56 (2003) 955-962
16. Sanchis J., Bodí V., Núñez J., et al. Limitations of clinical history for evaluation of patients with acute chest pain, non-diagnostic electrocardiogram and normal troponin. Am J Cardiol 101 (2008) 613-617
17. Sanchis J., Bodí V., Núñez J., et al. Efficacy of coronary revascularization in patients with acute chest pain managed in chest pain unit. Mayo Clin Proc 84 (2009) 323-329
18. d'Souza S.P., Yellon D.M., Martin C., et al. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol (Heart Cir Physiol) 284 (2003) H1592-H1600
19. d'Souza S.P., and Baxter G.F. B-type natriuretic peptide: a good omen in myocardial ischemia. Heart 97 (2003) 707-709
20. De Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Eng J Med 345 (2001) 1014-1021
21. Jernberg T., Stridsberg M., Venge P., et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40 (2002) 437-445
22. Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction. B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41 (2003) 1262-1272
23. Heeschen C., Hamm C.W., Mitrovic V., et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
24. Galvani M., Ottani F., Oltrona L., et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 110 (2004) 128-134
25. Weber M., Bazzino O., Navarro J.L., et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol 51 (2008) 1188-1195
26. Huelsmann M., Neuhold S., Strunk G., et al. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 29 (2008) 2259-2264